The Clinical and Psychosocial Impact of Peyronie’s Disease
Volume: 19
Issue: 4 Suppl
Managing Costs in High-Risk Obstetrics
Type 2 Diabetes and the Evolving Paradigm in Glucose Regulation
Issue: 3 Suppl
Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CPE]
Issue: 2 Suppl
Unmet Need in the Treatment of Postherpetic Neuralgia
Issue: 1 Suppl
Chronic Obstructive Pulmonary Disease From a Payer and Provider Lens
Battling a Stormy C: Addressing Managed Care Challenges and Opportunities in Management of Hepatitis
Volume: 18
Issue: 14 Suppl
Improving Clinical and Managed Care Outcomes in Rheumatoid arthritis: a Focus on Comparative Effecti
Issue: 13 Suppl
Improving Outcomes for Restless Legs Syndrome: Considerations for Managed Care—A Clinician and Pay
Issue: 12 Suppl
New Approaches to Measuring Value in Oncology Therapy
Issue: 11 Suppl
Emerging Type 2 Diabetes Treatment Strategies: Practical Solutions for a Complex Environment [CME/CP
Issue: 10 Suppl
A Novel Gastroretentive Formulation of Gabapentin for the Treatment of Postherpetic Neuralgia
Issue: 9 Suppl
Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Re
Issue: 8 Suppl
Best Practices for Treating Parkinson’s Disease: A Focus on Symptoms and Considerations for Manage
Issue: 7 Suppl
The Aligning Forces for Quality Initiative: Early Lessons From Efforts to Improve Healthcare Quality
Issue: 6 Suppl
Improving Outcomes for Restless Legs Syndrome: Considerations for Managed Care—a Clinician and Pay
Issue: 5 Suppl
Considerations for the Optimal Use of Immunoglobulin
Systemic Lupus Erythematosus: A Primer for Managed Care
Improving Adherence in the Treatment of Type 2 Diabetes Mellitus: Opportunities for Managed Care
2011 V-BID Center Symposium: The State of Value-Based Insurance Design
The Role of Inhaled Corticosteroids in Asthma Treatment: A Health Economic Perspective
Understanding the Mechanisms to Maintain Glucose Homeostasis: A Review for Managed Care [CPE]
Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care Environment [CME/CPE
Volume: 17
Issue: 18 Suppl
The Benefits of Specific Immunoglobulin E Testing in the Primary Care Setting
Issue: 17 Suppl
Understanding Dry Eye Disease: A Managed Care Perspective [CME/CPE]
Issue: 16 Suppl
Community on Payment Innovations Newsletter - Dec 2011
Improving Outcomes in Chronic Kidney Disease: Optimizing Management of Cardiovascular Diseases [CME/
Issue: 15 Suppl
Improving Treatment Success Rates for Type 2 Diabetes: Balancing Safety, Cost, and Outcome [CME/CPE]
Optimizing Outcomes in the Management of Alzheimer's Disease
![Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CPE]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F6594629bd041f089213fa76b19562bda6baeb63d-300x409.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CPE]")
![Understanding the Mechanisms to Maintain Glucose Homeostasis: A Review for Managed Care [CPE]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F2848ffb7793f70b18cbd80c13bb70b257368e87d-288x393.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Understanding the Mechanisms to Maintain Glucose Homeostasis: A Review for Managed Care [CPE]")
![Understanding Dry Eye Disease: A Managed Care Perspective [CME/CPE]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2F5706967c39f3bf53de451bd2b482c06f988edfcf-879x1200.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Understanding Dry Eye Disease: A Managed Care Perspective [CME/CPE]")
![Improving Treatment Success Rates for Type 2 Diabetes: Balancing Safety, Cost, and Outcome [CME/CPE]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fe7bf06f414f6698bc815f2ebaeb0cd641f00ce58-879x1200.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Improving Treatment Success Rates for Type 2 Diabetes: Balancing Safety, Cost, and Outcome [CME/CPE]")
